Early Alzheimer’s Study Finds Nanoparticle May Help Deliver Treatments Directly to Brain

Early Alzheimer’s Study Finds Nanoparticle May Help Deliver Treatments Directly to Brain
Researchers found that the combination of titanate, a nanoparticle that can penetrate the brain-blood barrier, and cerebrolysin, used in some parts of the world to treat problems with cognition, had superior neuroprotective effects in an animal model of Alzheimer’s disease than cerebrolysin alone. The study, “Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *